Michael Van Zandt

Michael joined the GBG team in 2020. As President & Chief Executive Officer, he provides leadership, oversight, and coordination for the development and management of new drug discovery platforms within NEDP.

Michael is an accomplished synthetic organic and medicinal chemist with more than 20 years of experience in large and small pharmaceutical company environments. Before founding NEDP, he was a department head and project leader for The Institute for Pharmaceutical Discovery (IPD) and a medicinal chemist at Bayer's pharmaceutical division. Michael, an inventor of more than 30 issued patents and author of more than 20 publications in peer-reviewed journals, is a frequent reviewer for the Journal of Medicinal Chemistry and Bioorganic Medicinal Chemistry Letters.

Michael received his Ph.D. in Organic Chemistry with a minor in Biochemistry while working with Distinguished Professor Carl R. Johnson at Wayne State University.